s6y
Company name or ticker
Search
Ernexa Therapeutics Inc.
3
Polinsky David: Initial statement of beneficial ownership of securities
Filed
Thursday, August 27, 2026
Period
Aug 4, 2026
Accession number
0001493152-26-040466
Documents
3
3
On sec.gov
Filing index
All files
Complete submission text
SGML header